Related Experiment Videos

MBP-1 mediated apoptosis involves cytochrome c release from mitochondria

Asish K Ghosh1, Mainak Majumder, Robert Steele

  • 1Department of Pathology, Saint Louis University, St. Louis, Missouri, MO 63104, USA.

Oncogene
|April 26, 2002
PubMed

Insights

The cellular factor MBP-1 induces apoptosis in human carcinoma cells by downregulating Bcl-xL expression, leading to mitochondrial cytochrome c release and caspase activation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • MBP-1 is a cellular factor implicated in transcriptional modulation, apoptosis, and cell growth.
  • Understanding the precise signaling pathways of MBP-1-mediated apoptosis is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the signaling pathway of MBP-1-mediated apoptotic cell death.
  • To elucidate the mechanism by which MBP-1 induces apoptosis, focusing on its interaction with the Bcl-2 gene family.

Main Methods:

  • Human carcinoma cells were infected with adenovirus expressing MBP-1 (AdMBP-1) or a control adenovirus.
  • Apoptosis was assessed by monitoring cytochrome c release, caspase activation (procaspase-9, procaspase-3), and PARP cleavage.
  • Bcl-xL mRNA and protein expression levels were quantified.
  • In vitro transient reporter assays were used to evaluate Bcl-x promoter activity.

Main Results:

  • AdMBP-1 infection induced apoptosis in human carcinoma cells, evidenced by cytochrome c release and caspase activation.
  • MBP-1 selectively reduced Bcl-xL mRNA and protein expression in MCF-7 cells.
  • Reporter assays indicated that MBP-1 represses Bcl-x promoter activity.
  • MBP-1 was found to modulate Ets family protein function, contributing to Bcl-xL downregulation.

Conclusions:

  • MBP-1 induces apoptosis through a mitochondrial pathway involving cytochrome c release and caspase activation.
  • MBP-1 selectively represses Bcl-xL expression in breast carcinoma cells, suggesting a novel mechanism of apoptotic induction.
  • The findings highlight MBP-1 as a potential target for cancer treatment by modulating Bcl-xL expression.

Related Concept Videos